跳转到主要内容
搜索
事实资料表

Expedited Pharmacometrics Regulatory Submissions

Skip to PDF content

Connect with Certara

Connect with a Certara pharmacometrics consultant to discuss your regulatory objectives and map out an accelerated PMx plan.

了解更多信息

精选推荐

How Certara Enabled Fruquintinib FDA Approval for Metastatic Colorectal Cancer
How Certara Enabled Fruquintinib FDA Approval for Metastatic Colorectal CancerCase Study

How Certara Enabled Fruquintinib FDA Approval for Metastatic Colorectal Cancer

ICH M15 Guideline: What the Finalized Guideline Means for Model-Informed Drug Development
ICH M15 Guideline: What the Finalized Guideline Means for Model-Informed Drug DevelopmentBlog

ICH M15 Guideline: What the Finalized Guideline Means for Model-Informed Drug Development

Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD)
Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD)Guide

Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD)

沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software